• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchMetacrine
    Picture of Metacrine logo

    MTCR — Metacrine News Story

    $0.580.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro Cap
    • Market Cap
      $25.48m
    • Enterprise Value
      -$13.48m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • MTCR Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    MTCR Dividends
    All News

    NASDAQ RESUMED AT 11:31 AM

    Picture of Metacrine logoMetacrine
    16/09/2020 16:31
    NASDAQ RESUMED  MTCR.O  AT 11:31 AM
    

    Recent news on Metacrine

    See all news
    • Metacrine Inc expected to post a loss of 14 cents a share - Earnings Preview

      24/03/2023 22:29
    • Brief: Metacrine - Filed Certificate Of Dissolution With Secretary Of State Of State Of Delaware To Effect Complete Liquidation And Dissolution Of Company

      24/03/2023 21:38
    • Brief: Metacrine Inc Common Stock Will Be Delisted From Nasdaq

      03/03/2023 22:31
    • Brief: Metacrine Inc- On Jan 31, Received Notice Of Delisting Or Failure To Satisfy Continued Listing Rule Or Standard From Nasdaq

      02/02/2023 24:02
    • Brief: Metacrine CEO Preston Klassen Was Terminated From All Positions

      24/01/2023 22:20

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.